SURGERY Journal

@SurgJournal · New York, USA · joined 09 May 2015

Official journal of Central Surgical Association, @TheAAES, & @UnivSurg. Editors in Chief @SWexner & @CaitlinWHicks Impact factor 4.348

25 513Followers

2 928Following

12 320Posts total

19.4KViews on collected posts

Son gönderiler

SURGERY Journal@SurgJournal3 Sep

🎥⚠️New video Alert! Best in Surgery: “There’s a Target on You”: Female Neurosurgeons’ & Cardiothoracic Surgeons Experiences of Overt & Covert Discrimination in the Workplace @GranekLeeat @SWexner @juliomayol @CaitlinWHicks #SoMe4Surgery https://t.co/h5jqbMIQtN via @YouTube 2K views · 5 likes · 4 reposts · 0 replies Open on X →

SURGERY Journal@SurgJournal16 Aug

Hypoglycemia is a strong independent predictor of mortality in acute calculous cholecystitis #OpenAccess ⚠️ https://t.co/cIrOBSF4BO @ShacharLaks @Wolfson_Med @SWexner @CaitlinWHicks @juliomayol @debby_keller @SyedAAhmad5 @shimulshah73 @luciacolorectal #SoMe4Surgery https://

3.7K views · 16 likes · 8 reposts · 0 replies Open on X →

SURGERY Journal@SurgJournal2 Aug

Do surgeons dream of electric sheep? The cost of favoring artificial intelligence over human judgement in surgery and surgical science👇🏻 https://t.co/E1dp2mtog7 @MaxMeneveauMD @vz_surgery @SWexner @CaitlinWHicks @juliomayol @SyedAAhmad5 @debby_keller #SoMe4Surgery #AI htt

GIF

4.7K views · 13 likes · 11 reposts · 0 replies Open on X →

SURGERY Journal@SurgJournal2 Aug

Make sure not to miss the August issue! So many exciting articles to read on various topics from AI language models to predictors of mortality in acute calculous cholecystitis. Make sure to check it out👇🏻 https://t.co/sAMMTB1MhB @SWexner @CaitlinWHicks #SoMe4Surgery https://

GIF

2.7K views · 8 likes · 4 reposts · 0 replies Open on X →

SURGERY Journal@SurgJournal23 Mar

@SurgJournal @Abe_laparoscopy @juliomayol @SWexner @CaitlinWHicks @debby_keller @SyedAAhmad5 @A160186 @luciacolorectal @CentralSurg @TheAAES @EndoSurgBSM @shimulshah73 @nlavellaneda @dr_samehhany81 @GaertnerWB @PipeCabreraV @hayfarani @Laparoscopes @aminmadaniMD @GianlucaPellino 186 views · 1 likes · 0 reposts · 0 replies Open on X →

SURGERY Journal@SurgJournal21 Mar

🌟Artificial intelligence for global surgery: Bridging gaps in low-resource settings🌟 https://t.co/JrFPhR0g21 @Abe_laparoscopy @juliomayol @SWexner @CaitlinWHicks @debby_keller @SyedAAhmad5 @A160186 @luciacolorectal @CentralSurg @TheAAES @EndoSurgBSM #SoMe4Surgery https://

6K views · 17 likes · 9 reposts · 2 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 4 gönderi, 10K–100K takipçi aralığıyla yan yana. geniş kitleye gösteriliyor, ama izleyenlerin azı tepki veriyor.

Medyan görüntülenme3 214bu hesap95410K–100K için medyan

Erişim, %12.60%bu hesap3.32%10K–100K için medyan

Etkileşim, %0.55%bu hesap1.87%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	3 214	954	3.37×
Erişim (görüntülenme ÷ takipçi)	12.60%	3.32%	3.79×
Etkileşim oranı	0.55%	1.87%	0.30×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

6K21 Mar

18623 Mar

2.7K2 Aug

4.7K

3.7K16 Aug

2K3 Sep

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.48%21 Mar

0.54%23 Mar

0.56%2 Aug

0.55%

0.67%16 Aug

0.45%3 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.87%.

What the audience does

Likes50.4%60 in total

Reposts30.3%36 in total

Replies1.7%2 in total

Quotes5.9%7 in total

Bookmarks11.8%14 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.